Cencora (0HF3.L)
0HF3.L Stock Price Chart
Explore Cencora interactive price chart. Choose custom timeframes to analyze 0HF3.L price movements and trends.
0HF3.L Company Profile
Discover essential business fundamentals and corporate details for Cencora (0HF3.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Distribution
IPO Date
29 Jan 2018
Employees
42.00K
CEO
Robert P. Mauch PharmD
Description
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
0HF3.L Financial Timeline
Browse a chronological timeline of Cencora corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 3 Feb 2026
Upcoming earnings on 4 Nov 2025
Upcoming earnings on 29 Jul 2025
Revenue estimate is $80.34B.
Dividend declared on 16 May 2025
A dividend of $0.55 per share was announced, adjusted to $0.55. The dividend was paid on 2 Jun 2025.
Earnings released on 7 May 2025
EPS came in at $4.42 surpassing the estimated $4.11 by +7.54%, while revenue for the quarter reached $75.50B, missing expectations by -7.14%.
Dividend declared on 14 Feb 2025
A dividend of $0.55 per share was announced, adjusted to $0.55. The dividend was paid on 3 Mar 2025.
Earnings released on 5 Feb 2025
EPS came in at $2.50 falling short of the estimated $3.50 by -28.57%, while revenue for the quarter reached $81.49B, beating expectations by +8.26%.
Dividend declared on 15 Nov 2024
A dividend of $0.55 per share was announced, adjusted to $0.55. The dividend was paid on 29 Nov 2024.
Earnings released on 6 Nov 2024
EPS came in at $0.02 falling short of the estimated $3.23 by -99.47%, while revenue for the quarter reached $79.05B, beating expectations by +1.84%.
Dividend declared on 9 Aug 2024
A dividend of $0.51 per share was announced, adjusted to $0.51. The dividend was paid on 26 Aug 2024.
Earnings released on 31 Jul 2024
EPS came in at $2.42 falling short of the estimated $3.22 by -24.84%, while revenue for the quarter reached $74.24B, beating expectations by +1.26%.
Dividend declared on 9 May 2024
A dividend of $0.51 per share was announced, adjusted to $0.51. The dividend was paid on 24 May 2024.
Earnings released on 1 May 2024
EPS came in at $2.09 falling short of the estimated $3.69 by -43.36%, while revenue for the quarter reached $68.41B, missing expectations by -3.09%.
Earnings released on 13 Mar 2024
EPS came in at $2.98 surpassing the estimated $2.90 by +2.76%, while revenue for the quarter reached $72.25B, beating expectations by +4.33%.
Dividend declared on 8 Feb 2024
A dividend of $0.51 per share was announced, adjusted to $0.51. The dividend was paid on 26 Feb 2024.
Dividend declared on 10 Nov 2023
A dividend of $0.51 per share was announced, adjusted to $0.51. The dividend was paid on 27 Nov 2023.
Earnings released on 2 Nov 2023
EPS came in at $1.72 falling short of the estimated $2.81 by -38.79%, while revenue for the quarter reached $68.92B, beating expectations by +4.03%.
Dividend declared on 10 Aug 2023
A dividend of $0.49 per share was announced, adjusted to $0.49. The dividend was paid on 28 Aug 2023.
Earnings released on 2 Aug 2023
EPS came in at $2.35 falling short of the estimated $2.82 by -16.67%, while revenue for the quarter reached $66.95B, beating expectations by +4.72%.
Dividend declared on 11 May 2023
A dividend of $0.49 per share was announced, adjusted to $0.49. The dividend was paid on 30 May 2023.
Earnings released on 2 May 2023
EPS came in at $2.13 falling short of the estimated $3.30 by -35.45%, while revenue for the quarter reached $63.46B, beating expectations by +4.96%.
Dividend declared on 9 Feb 2023
A dividend of $0.49 per share was announced, adjusted to $0.49. The dividend was paid on 27 Feb 2023.
Earnings released on 1 Feb 2023
EPS came in at $2.33 falling short of the estimated $2.64 by -11.74%, while revenue for the quarter reached $62.85B, beating expectations by +0.06%.
Dividend declared on 10 Nov 2022
A dividend of $0.49 per share was announced, adjusted to $0.49. The dividend was paid on 28 Nov 2022.
Earnings released on 30 Sept 2022
EPS came in at $1.40 falling short of the estimated $2.57 by -45.53%, while revenue for the quarter reached $61.17B, beating expectations by +1.05%.
Dividend declared on 12 Aug 2022
A dividend of $0.46 per share was announced, adjusted to $0.46. The dividend was paid on 29 Aug 2022.
Earnings released on 30 Jun 2022
EPS came in at $1.92 falling short of the estimated $2.56 by -25.00%, while revenue for the quarter reached $60.06B, beating expectations by +1.67%.
Dividend declared on 13 May 2022
A dividend of $0.46 per share was announced, adjusted to $0.46. The dividend was paid on 31 May 2022.
Earnings released on 31 Mar 2022
EPS came in at $2.59 falling short of the estimated $2.92 by -11.30%, while revenue for the quarter reached $57.72B, beating expectations by +0.41%.
Dividend declared on 11 Feb 2022
A dividend of $0.46 per share was announced, adjusted to $0.46. The dividend was paid on 28 Feb 2022.
Earnings released on 31 Dec 2021
EPS came in at $2.13, while revenue for the quarter reached $59.63B.
Dividend declared on 12 Nov 2021
A dividend of $0.46 per share was announced, adjusted to $0.46. The dividend was paid on 29 Nov 2021.
Earnings released on 30 Sept 2021
EPS came in at $2.08 falling short of the estimated $2.58 by -19.38%, while revenue for the quarter reached $58.91B, missing expectations by -1.15%.
Dividend declared on 13 Aug 2021
A dividend of $0.44 per share was announced, adjusted to $0.44. The dividend was paid on 7 Sept 2021.
Earnings released on 30 Jun 2021
EPS came in at $1.40, while revenue for the quarter reached $53.41B.
Dividend declared on 14 May 2021
A dividend of $0.44 per share was announced, adjusted to $0.44. The dividend was paid on 1 Jun 2021.
Earnings released on 31 Mar 2021
EPS came in at $2.10, while revenue for the quarter reached $49.15B.
Dividend declared on 11 Feb 2021
A dividend of $0.44 per share was announced, adjusted to $0.44. The dividend was paid on 1 Mar 2021.
Earnings released on 31 Dec 2020
EPS came in at $1.81, while revenue for the quarter reached $52.52B.
Dividend declared on 13 Nov 2020
A dividend of $0.44 per share was announced, adjusted to $0.44. The dividend was paid on 30 Nov 2020.
Earnings released on 30 Sept 2020
EPS came in at -$23.74, while revenue for the quarter reached $49.24B.
Dividend declared on 5 Aug 2020
A dividend of $0.42 per share was announced, adjusted to $0.42. The dividend was paid on 1 Sept 2020.
0HF3.L Stock Performance
Access detailed 0HF3.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.